MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

The Implied Analyst 12-Month Target For ESML
Monday, November 2, 7:46 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Krystal Biotech (KRYS) Shares Cross Above 200 DMA
Tuesday, November 24, 1:40 PM ET, by Market News Video Staff

In trading on Tuesday, shares of Krystal Biotech Inc (KRYS) crossed above their 200 day ...

Notable Friday Option Activity: LULU, VRM, KRYS
Friday, May 7, 3:28 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Investors Snatch KRYS Even Cheaper Than Its Secondary Stock Offering
Monday, May 10, 3:18 PM ET, by Market News Video Staff

Looking back to 97 days ago, Krystal Biotech Inc (KRYS) priced a 1,923,077 share secondary ...

Krystal Biotech is Now Oversold (KRYS)
Thursday, May 13, 12:07 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Relative Strength Alert For Krystal Biotech

By Market News Video Staff, Tuesday, July 27, 12:14 PM ET
Play Video: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Tuesday, shares of Krystal Biotech Inc (NASDAQ:KRYS) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $55.01 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 59.8. A bullish investor could look at KRYS's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of KRYS shares:

Krystal Biotech Inc 1 Year Performance Chart

Looking at the chart above, KRYS's low point in its 52 week range is $39.3933 per share, with $87.2874 as the 52 week high point — that compares with a last trade of $55.17. Find out what 9 other oversold stocks you need to know about »


Free Report: Top 7%+ Dividends (paid monthly)


This Article's Word Cloud:   About   Biotech   Buffett   Dividends   Find   Free   Index   KRYS   Know   Krystal   Legendary   Looking   Oversold   Relative   Report   Should   Start   Stocks   Strength   Tuesday   Warren   about   above   advises   after   analysis   begin   below   bullish   called   changing   chart   compares   comparison   fearful   greedy   investor   look   others   oversold   point   raquo   reading   share   shares   stock   that   week   when   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

Relative Strength Alert For Krystal Biotech | Market News Video | Copyright © 2008 - 2021, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.